Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Carnegie in connection with the acquisition of Erik Penser Bank’s securities business
Mandate

Vinge advises Carnegie in connection with the acquisition of Erik Penser Bank’s securities business

October 25, 2023 Employment and Benefits Private Funds Intellectual Property M&A Banking and Finance

Vinge has advised Carnegie Investment Bank AB in connection with the acquisition of the business sectors Erik Penser Wealth Management and Erik Penser Corporate Finance as well as the analytical services Penser Access and Penser Future from Erik Penser Bank AB. The consideration for the completed purchase consists of shares in Carnegie and the acquisition is subject to customary conditions from public authorities.

Carnegie Group is currently the Nordic region’s leading financial adviser and asset manager with 800 employees in six countries. Erik Penser Bank offers an extensive portfolio of financial services and was founded through the establishment of Erik Penser Fondkommission in 1994 by Erik Penser.

Vinge’s team primarily consisted of Kristian Ford (responsible partner), Sofie Nordgren, Anna Edström, Henrik Borna and Agaton Lindgren (M&A), Nils Unckel, Anton Sjökvist and Viktoria Wnuk (regulatory), Pär Remnelid (competition), Emelie Svensäter Jerntorp (employment), Lisa Bourghardt (IP), Fredrik Christiansson (banking and finance) and Ulf Nilsson (tax).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025